Tenax Therapeutics (TENX) Amortizatization of Intangibles (2019 - 2022)
Tenax Therapeutics (TENX) posted quarterly Amortizatization of Intangibles of $27857.0 for Q4 2022, up 8.18% year-over-year from $25751.0 in Q4 2021, and up 2.03% on a QoQ basis from $27303.0 in Q3 2022.
Tenax Therapeutics (TENX) Amortizatization of Intangibles (2019 - 2022) Analysis & Trends
Tenax Therapeutics has reported Amortizatization of Intangibles for 4 years, with the latest figure at $27857.0 in Q4 2022.
- Amortizatization of Intangibles for Q4 2022 came in at $27857.0, up 8.18% year-over-year; the trailing twelve-month figure through Jun 2023 was $55160.0 (down 46.98% YoY), and the FY2022 annual result was $108189.0, up 3.17% from the prior year.
- Amortizatization of Intangibles rose to $27857.0 in Q4 2022, from $27303.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $29088.0 in Q1 2021 and troughed at $24771.0 in Q2 2021.
- A 4-year average of $26624.2 and a median of $26546.0 in 2019 frame the typical range for Amortizatization of Intangibles.
- The widest annual swing landed in 2021, when Amortizatization of Intangibles increased 8.37%; it then retreated 9.73% in 2022.
- A 4-year view of Amortizatization of Intangibles shows it stood at $26320.0 in 2019, then advanced by 8.31% to $28508.0 in 2020, then fell by 9.67% to $25751.0 in 2021, then increased by 8.18% to $27857.0 in 2022.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $27857.0 in Q4 2022, $27303.0 in Q3 2022, and $26772.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 27,857.00 |
| Dec 31, 2022 | 27,857.00 |
| Sep 30, 2022 | 27,303.00 |
| Sep 30, 2022 | 27,303.00 |
| Jun 30, 2022 | 26,772.00 |
| Jun 30, 2022 | 26,772.00 |
| Mar 31, 2022 | 26,257.00 |
| Mar 31, 2022 | 26,257.00 |
| Dec 31, 2021 | 25,751.00 |
| Dec 31, 2021 | 25,751.00 |
| Sep 30, 2021 | 25,256.00 |
| Sep 30, 2021 | 25,256.00 |
| Jun 30, 2021 | 24,771.00 |
| Jun 30, 2021 | 24,771.00 |
| Mar 31, 2021 | 29,088.00 |
| Mar 31, 2021 | 29,088.00 |
| Dec 31, 2020 | 28,508.00 |
| Dec 31, 2020 | 28,508.00 |
| Sep 30, 2020 | 27,940.00 |
| Sep 30, 2020 | 27,940.00 |